Aetion – Page 3 – Healthcare Data News

March 8, 2022March 11, 2022 AI Collaborations Competitor News Data Partnership

Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer’s Disease

March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence...

March 8, 2022March 9, 2022 Academic Competitor News Europe International RWE Study

Advancing digital health applications: priorities for innovation in real-world evidence generation

Ariel D Stern 1, Jan Brönneke 2, Jörg F Debatin 2, Julia Hagen 2, Henrik Matthies 2, Smit Patel 3, Ieuan Clay 4, Bjoern Eskofier 5, Annika Herr 6, Kurt Hoeller 7, Ashley Jaksa 8, Daniel B Kramer 9, Mattias Kyhlstedt 10, Katherine T Lofgren 11, Nirosha Mahendraratnam 12, Holger Muehlan 13, Simon Reif 14, Lars Riedemann 15, Jennifer C Goldsack 3 Affiliations 1Technology and Operations Management...

January 5, 2022 AI Competitor News M&A

Aetion acquires synthetic data trailblazer Replica Analytics

NEW YORK and OTTAWA, ON, Jan. 4, 2022 /PRNewswire/ — Aetion, the leading regulatory-grade real-world evidence (RWE) technology provider, today announced that it has acquired Replica Analytics, a pioneer in using artificial intelligence (AI)...

December 1, 2021December 1, 2021 Collaborations Competitor News Europe Government/Regulatory International

European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe

BARCELONA, Spain, Dec. 1, 2021 /PRNewswire/ — The European Medicines Agency (EMA) has selected Aetion for a four-year term to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion will...

October 21, 2021January 5, 2022 Collaborations Competitor News COVID-19 Data Partnership Government/Regulatory

FDA selects Aetion Evidence Platform® to advance regulatory science and innovation

NEW YORK, NY, October 21, 2021 — Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study...

October 6, 2021December 1, 2021 Collaborations Competitor News Government/Regulatory

Aetion and NICE Announce Collaboration to Explore Use of Real-World Evidence for Comparative Effectiveness Studies to Inform Clinical Guidance

Collaboration will leverage the Aetion Evidence Platform® to study when and how RWE can support the agency’s decision-making NEW YORK, NY & MANCHESTER, ENGLAND, October 6, 2021 — Aetion today announced a collaboration...

September 22, 2021January 5, 2022 AI Collaborations Competitor News Data Partnership Product Updates

Aetion and Quinten Health partner to use AI and RWE to reduce research timelines

NEW YORK AND PARIS, September 22, 2021 — Quinten Health, a Paris-based AI solutions company, and Aetion, a global real-world evidence (RWE) technology provider, announce a strategic partnership to offer...

September 14, 2021January 5, 2022 Competitor News HR

Aetion welcomes Marla Kessler as first Chief Customer Officer to accelerate its next phase of growth

The company adds the life sciences and technology leader to its executive team as it continues to drive global RWE innovation. Aetion, a leading health technology company, announces that Marla Kessler will...